The Senate Finance Committee today approved by voice vote legislation to extend funding for the Children’s Health Insurance Program through fiscal year 2022. Under the KIDS Act (S. 1827), the program’s federal matching rate would remain at 23% through FY 2019, change to 11.5% for FY 2020 and return to a traditional CHIP matching rate for FYs 2021 and 2022. The House Energy and Commerce Committee is marking up a similar bill this afternoon. In addition, the House bill would delay the Medicaid disproportionate share hospital cuts for FY 2018, but add two more years of cuts for 2026 and 2027; and would provide $1 billion in Medicaid funding to Puerto Rico. Offsets in the House bill include changes to Medicaid third party liability and treatment of lottery winnings and other lump-sum income for purposes of income eligibility under Medicaid, as well as adjustments to Medicare Part B and Part D premium subsidies for higher-income individuals. CHIP covers 8.9 million children with family incomes above Medicaid eligibility limits who lack access to affordable private coverage. While the program is authorized through Oct. 1, 2019, legislative action is needed to reauthorize funding, which expired Sept. 30.

Related News Articles

Headline
The U.S. Departments of Labor, Health and Human Services, and the Treasury announced Aug. 7 that they are reconsidering the definition of short-term, limited-…
Headline
A new analysis published Aug. 6 by the Peterson Center on Healthcare and KFF found that Health Insurance Marketplace insurers will propose a median premium…
Headline
Nearly 57% of mothers did not attend a postpartum follow-up visit three to eight weeks after giving birth, according to a report published July 29 by Cedar…
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Perspective
House members are back in their districts for the August recess and senators are likely to return to their states soon.While lawmakers are home, it’s important…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…